X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
female (121) 121
male (111) 111
index medicus (106) 106
middle aged (104) 104
aged (97) 97
oncology (85) 85
adult (84) 84
aged, 80 and over (51) 51
cancer (40) 40
prognosis (33) 33
retrospective studies (31) 31
treatment outcome (29) 29
chemotherapy (28) 28
clinical neurology (28) 28
article (24) 24
survival analysis (24) 24
survival (23) 23
tumors (23) 23
adolescent (20) 20
neoplasm staging (20) 20
survival rate (20) 20
young adult (20) 20
angiogenesis (19) 19
disease progression (19) 19
disease-free survival (19) 19
pathology (19) 19
care and treatment (18) 18
lung neoplasms - drug therapy (18) 18
mutation (18) 18
surgery (17) 17
kaplan-meier estimate (16) 16
abridged index medicus (15) 15
cohort studies (15) 15
neoplasm recurrence, local - drug therapy (15) 15
risk factors (15) 15
therapy (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
carcinoma, non-small-cell lung - drug therapy (14) 14
endothelial growth-factor (14) 14
follow-up studies (14) 14
bevacizumab (13) 13
brain neoplasms - drug therapy (13) 13
expression (13) 13
glioblastoma (13) 13
receptor, epidermal growth factor - genetics (13) 13
lung neoplasms - pathology (12) 12
neurology (12) 12
quality of life (12) 12
research (12) 12
animals (11) 11
antineoplastic agents - therapeutic use (11) 11
carcinoma (11) 11
child (11) 11
diagnosis (11) 11
gefitinib (11) 11
immunohistochemistry (11) 11
lung neoplasms - genetics (11) 11
mice (11) 11
trial (11) 11
cell line, tumor (10) 10
cell lung-cancer (10) 10
cells (10) 10
combination (10) 10
drug administration schedule (10) 10
glioblastoma - drug therapy (10) 10
magnetic resonance imaging (10) 10
management (10) 10
multivariate analysis (10) 10
neoplasm recurrence, local - pathology (10) 10
neurosciences (10) 10
respiratory system (10) 10
skin neoplasms - pathology (10) 10
brain neoplasms - mortality (9) 9
lung cancer (9) 9
melanoma (9) 9
multidisciplinary sciences (9) 9
neurofibromatosis (9) 9
non-small cell lung cancer (9) 9
phase-ii (9) 9
prospective studies (9) 9
analysis (8) 8
brain (8) 8
carcinoma, non-small-cell lung - genetics (8) 8
carcinoma, non-small-cell lung - pathology (8) 8
erlotinib (8) 8
hepatocellular carcinoma (8) 8
malignant glioma (8) 8
medicine & public health (8) 8
melanoma - pathology (8) 8
patients (8) 8
proportional hazards models (8) 8
receptor, epidermal growth factor - antagonists & inhibitors (8) 8
risk assessment (8) 8
time factors (8) 8
vascular endothelial growth factor (8) 8
adenocarcinoma (7) 7
angiogenesis inhibitors - therapeutic use (7) 7
antibodies, monoclonal, humanized (7) 7
biomarkers, tumor - metabolism (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 48 - 54
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 4, pp. 366 - 377
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2016, Volume 113, Issue 16, pp. 4476 - 4481
Inhibition of the vascular endothelial growth factor (VEGF) pathway has failed to improve overall survival of patients with glioblastoma (GBM). We previously... 
Anti-angiogenic therapy | Macrophage polarization | Tumor microenvironment | Microglia reprogramming | Anti-tumor immunity | anti-angiogenic therapy | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | macrophage polarization | RANDOMIZED-TRIAL | ANGIOPOIETIN-2 | CANCER | THERAPY | microglia reprogramming | TIE2-EXPRESSING MONOCYTES | BLOOD-VESSELS | TUMOR-ASSOCIATED MACROPHAGES | tumor microenvironment | NORMALIZATION | anti-tumor immunity | ENDOTHELIAL GROWTH-FACTOR | Macrophages - pathology | Antibodies, Bispecific - pharmacology | Vesicular Transport Proteins - metabolism | Humans | Neoplasm Proteins - antagonists & inhibitors | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Neoplasm Proteins - metabolism | Neoplasms, Experimental - pathology | Xenograft Model Antitumor Assays | Macrophages - metabolism | Vesicular Transport Proteins - antagonists & inhibitors | Animals | Antibodies, Neoplasm - pharmacology | Ribonuclease, Pancreatic - metabolism | Glioblastoma - pathology | Cell Line, Tumor | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Mice | Neoplasms, Experimental - metabolism | Glioblastoma - drug therapy | Ribonuclease, Pancreatic - antagonists & inhibitors | Neoplasms, Experimental - drug therapy | Viral antibodies | Care and treatment | Antibodies | Physiological aspects | Models | Macrophages | Vascular endothelial growth factor | Health aspects | Glioblastoma multiforme | Biological Sciences
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2016, Volume 113, Issue 16, pp. 4470 - 4475
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 15, pp. 2442 - 2449
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 940 - 10
A quantitative technique to detect cancer in single cells could transform cancer diagnosis. Current cancer diagnosis utilizes histopathology, which requires... 
CELLS | FINE-NEEDLE-ASPIRATION | MULTIDISCIPLINARY SCIENCES | BIOPSY | SIZE | DYNAMICS | CYTOLOGY | TUMORS | RHODAMINE-123 | Fluorescence polarization | Mitochondria | Fluorescence | Breast cancer | Diagnosis | Medical diagnosis | Localization | Cancer | Methylene blue
Journal Article
Journal Article
Journal of Neuropathology & Experimental Neurology, ISSN 0022-3069, 06/2013, Volume 72, Issue 6, pp. 462 - 471
Journal Article